KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Net Income - Minority (2016 - 2021)

Historic Net Income - Minority for Gilead Sciences (GILD) over the last 11 years, with Q2 2021 value amounting to -$7.0 million.

  • Gilead Sciences' Net Income - Minority rose 9391.3% to -$7.0 million in Q2 2021 from the same period last year, while for Jun 2021 it was -$7.0 million, marking a year-over-year increase of 9391.3%. This contributed to the annual value of -$19.0 million for FY2020, which is 8480.0% up from last year.
  • Per Gilead Sciences' latest filing, its Net Income - Minority stood at -$7.0 million for Q2 2021, which was up 9391.3% from -$12.0 million recorded in Q1 2021.
  • In the past 5 years, Gilead Sciences' Net Income - Minority ranged from a high of -$7.0 million in Q2 2021 and a low of -$476.0 million during Q1 2017
  • In the last 5 years, Gilead Sciences' Net Income - Minority had a median value of -$120.0 million in 2019 and averaged -$144.2 million.
  • As far as peak fluctuations go, Gilead Sciences' Net Income - Minority tumbled by 14915.25% in 2018, and later soared by 9391.3% in 2021.
  • Quarter analysis of 5 years shows Gilead Sciences' Net Income - Minority stood at -$59.0 million in 2017, then plummeted by 149.15% to -$147.0 million in 2018, then rose by 14.97% to -$125.0 million in 2019, then soared by 84.8% to -$19.0 million in 2020, then soared by 63.16% to -$7.0 million in 2021.
  • Its Net Income - Minority was -$7.0 million in Q2 2021, compared to -$12.0 million in Q1 2021 and -$19.0 million in Q4 2020.